Loxo Oncology, Inc. Insider Trading for November 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Loxo Oncology, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Loxo Oncology, Inc. for November 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Option Exercise | M | 13.67 | 2,057 | 28,119 | 87,943 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Option Exercise | M | 3.65 | 2,443 | 8,912 | 40,326 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Option Exercise | M | 3.65 | 5,500 | 20,064 | 42,769 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 151.55 | 200 | 30,310 | 13,700 | 13.9 K to 13.7 K (-1.44 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 149.46 | 200 | 29,892 | 13,900 | 14.1 K to 13.9 K (-1.42 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 147.99 | 81 | 11,987 | 14,100 | 14.2 K to 14.1 K (-0.57 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 147.06 | 300 | 44,118 | 14,181 | 14.5 K to 14.2 K (-2.07 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 144.97 | 100 | 14,497 | 14,481 | 14.6 K to 14.5 K (-0.69 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 143.92 | 200 | 28,784 | 14,581 | 14.8 K to 14.6 K (-1.35 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 143.08 | 500 | 71,540 | 14,781 | 15.3 K to 14.8 K (-3.27 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 141.69 | 500 | 70,845 | 15,281 | 15.8 K to 15.3 K (-3.17 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 140.13 | 300 | 42,039 | 15,781 | 16.1 K to 15.8 K (-1.87 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 138.83 | 1,170 | 162,431 | 16,081 | 17.3 K to 16.1 K (-6.78 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 138.08 | 949 | 131,038 | 17,251 | 18.2 K to 17.3 K (-5.21 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Buy | M | 13.67 | 2,057 | 28,119 | 18,200 | 16.1 K to 18.2 K (+12.74 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Buy | M | 3.65 | 2,443 | 8,912 | 16,143 | 13.7 K to 16.1 K (+17.83 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 156.45 | 200 | 31,290 | 13,700 | 13.9 K to 13.7 K (-1.44 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 155.30 | 600 | 93,180 | 13,900 | 14.5 K to 13.9 K (-4.14 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 154.00 | 1,500 | 231,000 | 14,500 | 16 K to 14.5 K (-9.37 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 152.49 | 1,644 | 250,694 | 16,000 | 17.6 K to 16 K (-9.32 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Sell | S | 151.71 | 1,556 | 236,061 | 17,644 | 19.2 K to 17.6 K (-8.10 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Van Naarden Jacob | Chief Business Offi ... | Buy | M | 3.65 | 5,500 | 20,064 | 19,200 | 13.7 K to 19.2 K (+40.15 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Option Exercise | M | 11.35 | 1,250 | 14,188 | 20,000 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Option Exercise | M | 11.35 | 1,250 | 14,188 | 21,250 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 151.55 | 100 | 15,155 | 0 | 100 to 0 (-100.00 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 148.20 | 100 | 14,820 | 100 | 200 to 100 (-50.00 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 147.09 | 100 | 14,709 | 200 | 300 to 200 (-33.33 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 143.84 | 200 | 28,768 | 300 | 500 to 300 (-40.00 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 140.94 | 200 | 28,188 | 500 | 700 to 500 (-28.57 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 138.95 | 350 | 48,633 | 700 | 1.1 K to 700 (-33.33 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 137.89 | 200 | 27,578 | 1,050 | 1.3 K to 1.1 K (-16.00 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Buy | M | 11.35 | 1,250 | 14,188 | 1,250 | 0 to 1.3 K |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 156.04 | 100 | 15,604 | 0 | 100 to 0 (-100.00 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 155.13 | 300 | 46,539 | 100 | 400 to 100 (-75.00 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 153.30 | 100 | 15,330 | 400 | 500 to 400 (-20.00 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 152.39 | 250 | 38,098 | 500 | 750 to 500 (-33.33 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Sell | S | 151.57 | 500 | 75,785 | 750 | 1.3 K to 750 (-40.00 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Burstein Jennifer | Senior VP of Financ ... | Buy | M | 11.35 | 1,250 | 14,188 | 1,250 | 0 to 1.3 K |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 13.67 | 10,000 | 136,700 | 338,514 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 13.67 | 1,486 | 20,314 | 348,514 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 3.68 | 8,514 | 31,366 | 64,471 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Option Exercise | M | 1.18 | 29,000 | 34,336 | 27,459 | |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 151.56 | 200 | 30,312 | 164,407 | 164.6 K to 164.4 K (-0.12 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 149.25 | 400 | 59,700 | 164,607 | 165 K to 164.6 K (-0.24 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 148.06 | 250 | 37,015 | 165,007 | 165.3 K to 165 K (-0.15 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 147.09 | 600 | 88,254 | 165,257 | 165.9 K to 165.3 K (-0.36 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 144.61 | 700 | 101,227 | 165,857 | 166.6 K to 165.9 K (-0.42 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 143.35 | 859 | 123,138 | 166,557 | 167.4 K to 166.6 K (-0.51 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 142.45 | 634 | 90,313 | 167,416 | 168.1 K to 167.4 K (-0.38 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 141.48 | 690 | 97,621 | 168,050 | 168.7 K to 168.1 K (-0.41 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 140.14 | 700 | 98,098 | 168,740 | 169.4 K to 168.7 K (-0.41 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 138.94 | 2,638 | 366,524 | 169,440 | 172.1 K to 169.4 K (-1.53 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 137.92 | 2,329 | 321,216 | 172,078 | 174.4 K to 172.1 K (-1.34 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 13.67 | 10,000 | 136,700 | 174,407 | 164.4 K to 174.4 K (+6.08 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 156.20 | 664 | 103,717 | 164,407 | 165.1 K to 164.4 K (-0.40 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 155.08 | 2,210 | 342,727 | 165,071 | 167.3 K to 165.1 K (-1.32 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 154.07 | 676 | 104,151 | 167,281 | 168 K to 167.3 K (-0.40 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 152.75 | 1,995 | 304,736 | 167,957 | 170 K to 168 K (-1.17 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 152.04 | 3,655 | 555,706 | 169,952 | 173.6 K to 170 K (-2.11 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Sell | S | 150.99 | 800 | 120,792 | 173,607 | 174.4 K to 173.6 K (-0.46 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 13.67 | 1,486 | 20,314 | 174,407 | 172.9 K to 174.4 K (+0.86 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 3.65 | 8,514 | 31,059 | 172,921 | 164.4 K to 172.9 K (+5.18 %) |
| Nov 28 2018 | LOXO | Loxo Oncology, Inc ... | Bilenker Joshua H. | President & CEO | Buy | M | 1.18 | 29,000 | 34,336 | 164,407 | 135.4 K to 164.4 K (+21.42 %) |